MA56546A - Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci - Google Patents
Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ciInfo
- Publication number
- MA56546A MA56546A MA056546A MA56546A MA56546A MA 56546 A MA56546 A MA 56546A MA 056546 A MA056546 A MA 056546A MA 56546 A MA56546 A MA 56546A MA 56546 A MA56546 A MA 56546A
- Authority
- MA
- Morocco
- Prior art keywords
- pyrolo
- pharmaceutically acceptable
- acceptable salt
- carbonate compound
- pyrimidine skeleton
- Prior art date
Links
- -1 CARBONATE COMPOUND Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019113172 | 2019-06-18 | ||
| JP2019157375 | 2019-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56546A true MA56546A (fr) | 2022-04-27 |
Family
ID=74036949
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056544A MA56544A (fr) | 2019-06-18 | 2020-06-17 | Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci |
| MA056546A MA56546A (fr) | 2019-06-18 | 2020-06-17 | Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056544A MA56544A (fr) | 2019-06-18 | 2020-06-17 | Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20220233566A1 (fr) |
| EP (2) | EP3988174A4 (fr) |
| JP (2) | JP7354245B2 (fr) |
| KR (2) | KR20220012349A (fr) |
| CN (2) | CN114008064A (fr) |
| AU (2) | AU2020295167A1 (fr) |
| BR (2) | BR112021025341A2 (fr) |
| CA (2) | CA3143914A1 (fr) |
| MA (2) | MA56544A (fr) |
| MX (2) | MX2021015772A (fr) |
| TW (2) | TW202114708A (fr) |
| WO (2) | WO2020255978A1 (fr) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19618727C2 (de) * | 1996-05-09 | 2000-02-17 | Deutsches Krebsforsch | Herstellung alkylierter Nucleosid-3'-Phosphate |
| US7265096B2 (en) * | 2002-11-04 | 2007-09-04 | Xenoport, Inc. | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| DE602007012881D1 (en) * | 2006-07-18 | 2011-04-14 | Anadys Pharmaceuticals Inc | Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen |
| EP2231689B1 (fr) * | 2008-01-18 | 2016-07-20 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nouveaux nucléosides 7-déazapurine cytostatiques |
| KR101774429B1 (ko) * | 2009-02-06 | 2017-09-04 | 코크리스탈 파마, 아이엔씨. | 암 및 바이러스 감염 치료용 퓨린 뉴클레오시드 모노포스페이트 프로드럭 |
| CZ19731U1 (cs) * | 2009-04-22 | 2009-06-15 | Tuma@Stanislav | Zarízení pro výrobu elektrické energie a tepla z biomasy |
| CA2759131C (fr) * | 2009-04-22 | 2017-06-20 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | Nucleosides de 7-deazapurine destines a des usages therapeutiques |
| WO2013009735A1 (fr) | 2011-07-13 | 2013-01-17 | Merck Sharp & Dohme Corp. | Dérivés de nucléosides 5'-substitués et leurs procédés d'utilisation pour le traitement de maladies virales |
| WO2014124430A1 (fr) * | 2013-02-11 | 2014-08-14 | Emory University | Compositions thérapeutiques renfermant des nucléotides et des nucléosides et utilisations associées |
| WO2017165489A1 (fr) | 2016-03-23 | 2017-09-28 | Emory University | Agents antiviraux pour le traitement d'infections par le le virus zika et de la dengue |
| CN110325542A (zh) * | 2016-11-03 | 2019-10-11 | 劳伦斯·I·吴 | 克罗拉滨的前体药物 |
-
2020
- 2020-06-17 MA MA056544A patent/MA56544A/fr unknown
- 2020-06-17 US US17/619,379 patent/US20220233566A1/en active Pending
- 2020-06-17 MX MX2021015772A patent/MX2021015772A/es unknown
- 2020-06-17 CA CA3143914A patent/CA3143914A1/fr active Pending
- 2020-06-17 TW TW109120363A patent/TW202114708A/zh unknown
- 2020-06-17 AU AU2020295167A patent/AU2020295167A1/en not_active Abandoned
- 2020-06-17 KR KR1020217042461A patent/KR20220012349A/ko not_active Application Discontinuation
- 2020-06-17 AU AU2020298440A patent/AU2020298440B2/en not_active Expired - Fee Related
- 2020-06-17 BR BR112021025341A patent/BR112021025341A2/pt unknown
- 2020-06-17 KR KR1020217042459A patent/KR20220015433A/ko not_active Application Discontinuation
- 2020-06-17 CN CN202080044346.5A patent/CN114008064A/zh active Pending
- 2020-06-17 MA MA056546A patent/MA56546A/fr unknown
- 2020-06-17 WO PCT/JP2020/023660 patent/WO2020255978A1/fr unknown
- 2020-06-17 EP EP20827091.8A patent/EP3988174A4/fr not_active Withdrawn
- 2020-06-17 EP EP20825777.4A patent/EP3988173A4/fr not_active Withdrawn
- 2020-06-17 JP JP2021526816A patent/JP7354245B2/ja active Active
- 2020-06-17 CN CN202080044340.8A patent/CN113993877A/zh active Pending
- 2020-06-17 MX MX2021015973A patent/MX2021015973A/es unknown
- 2020-06-17 BR BR112021025443A patent/BR112021025443A2/pt unknown
- 2020-06-17 JP JP2021528277A patent/JP7354246B2/ja active Active
- 2020-06-17 US US17/619,401 patent/US20220267365A1/en active Pending
- 2020-06-17 WO PCT/JP2020/023661 patent/WO2020255979A1/fr unknown
- 2020-06-17 CA CA3143911A patent/CA3143911A1/fr active Pending
- 2020-06-17 TW TW109120365A patent/TW202114709A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3988174A1 (fr) | 2022-04-27 |
| CN114008064A (zh) | 2022-02-01 |
| WO2020255978A1 (fr) | 2020-12-24 |
| CA3143914A1 (fr) | 2020-12-24 |
| JPWO2020255978A1 (fr) | 2020-12-24 |
| TW202114708A (zh) | 2021-04-16 |
| TW202114709A (zh) | 2021-04-16 |
| BR112021025341A2 (pt) | 2022-02-01 |
| JP7354246B2 (ja) | 2023-10-02 |
| US20220267365A1 (en) | 2022-08-25 |
| JP7354245B2 (ja) | 2023-10-02 |
| US20220233566A1 (en) | 2022-07-28 |
| AU2020298440A1 (en) | 2022-01-20 |
| KR20220015433A (ko) | 2022-02-08 |
| CA3143911A1 (fr) | 2020-12-24 |
| MX2021015973A (es) | 2022-02-10 |
| EP3988174A4 (fr) | 2023-04-26 |
| MX2021015772A (es) | 2022-01-31 |
| EP3988173A1 (fr) | 2022-04-27 |
| MA56544A (fr) | 2022-04-27 |
| AU2020295167A1 (en) | 2022-02-03 |
| AU2020298440B2 (en) | 2023-10-05 |
| EP3988173A4 (fr) | 2023-08-02 |
| JPWO2020255979A1 (fr) | 2020-12-24 |
| CN113993877A (zh) | 2022-01-28 |
| BR112021025443A2 (pt) | 2022-02-01 |
| WO2020255979A1 (fr) | 2020-12-24 |
| KR20220012349A (ko) | 2022-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288802A (en) | Benzisoxazole sulfonamide derivatives | |
| EP3480198A4 (fr) | Nouveau composé ou son sel pharmaceutiquement accepté | |
| EP3773566A4 (fr) | Composés ox2r | |
| IL288987A (en) | New heterocyclic compounds | |
| ZA202107474B (en) | Sulcardine salts | |
| IL284940A (en) | Bicyclic sulfonamides | |
| EP3466945A4 (fr) | Sel pharmaceutiquement acceptable utilisé en tant qu'inhibiteur du canal à potassium de la medulla externe du rein | |
| MA56546A (fr) | Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci | |
| MA50937A (fr) | Nouveau composé isoxazole ou sel de celui-ci | |
| ZA202007034B (en) | The crystalline forms of a compound | |
| GB201919212D0 (en) | Dihydro-cyclopenta-isoquinoline sulfonamides derivatives | |
| MA41599A (fr) | Formes cristallines d'un composé pyrrolopyridine | |
| EP3803035A4 (fr) | Tête modulaire pour éléments tubulaires de puits | |
| GB201919216D0 (en) | Tetrahydrobenzo-quinoline sulfonamides derivative compounds | |
| DK3841862T3 (da) | Roterende klippehoved | |
| AU2019904248A0 (en) | Sulphonamide compounds | |
| IL290345A (en) | Pyrimidine-5-carboxamide compounds | |
| FIC20190048I1 (fi) | Lorlatinibi tai sen farmaseuttisesti hyväksyttävä suola | |
| GB201910865D0 (en) | Antagonist compounds | |
| ZA201907540B (en) | A rock trepanning tool | |
| FIC20190033I1 (fi) | Apalutamidi tai sen farmaseuttisesti hyväksyttävä suola | |
| FIC20190056I1 (fi) | talatsoparibi, valinnaisesti farmaseuttisesti hyväksyttävän suolan muodossa | |
| GB201913116D0 (en) | A shower head insert | |
| GB201904158D0 (en) | Antagonist compounds | |
| GB201907925D0 (en) | A&E direct |